Yutaka Kuroda

15PUBLICATIONS
26CO-AUTHORS
Nanotoxicology, health and safetyBiofabricationBiomaterialsInorganic materials (incl. nanomaterials)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 19, 2024
Non-Glycosylated SARS-CoV-2 Omicron BA.5 Receptor Binding Domain (RBD) with a Native-like Conformation Induces a Robust Immune Response with Potent Neutralization in a Mouse Model.

Rawiwan Wongnak, Subbaian Brindha, Mami Oba

|Apr 13, 2024
Design and Escherichia coli Expression of a Natively Folded Multi-Disulfide Bonded Influenza H1N1-PR8 Receptor-Binding Domain (RBD).

Thao Tu, Tharangani Rathnayaka, Toshiyo Kato

|Jul 14, 2023
Antisera Produced Using an E. coli-Expressed SARS-CoV-2 RBD and Complemented with a Minimal Dose of Mammalian-Cell-Expressed S1 Subunit of the Spike Protein Exhibits Improved Neutralization.

Takahiro Yoshizue, Subbaian Brindha, Rawiwan Wongnak

|Feb 11, 2023
The Immunogenicity of DENV1-4 ED3s Strongly Differ despite Their Almost Identical Three-Dimensional Structures and High Sequence Similarities.

Md Din Islam, Tahmina Sharmin, Imrul Hasan Tipo

|Dec 23, 2022
An Escherichia coli Expressed Multi-Disulfide Bonded SARS-CoV-2 RBD Shows Native-like Biophysical Properties and Elicits Neutralizing Antisera in a Mouse Model.

Subbaian Brindha, Takahiro Yoshizue, Rawiwan Wongnak

|Dec 05, 2022
Biophysical studies of amorphous protein aggregation and in vivo immunogenicity.

Yutaka Kuroda

Pageof 3

Frequent Collaborators

4 joint publications

Shun-Ichi Kidokoro

3 joint publications

Mami Oba

2 joint publications

Md Din Islam

2 joint publications

Kenji Mizutani